Clinical Trial Update: Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a cannabinoid agonist's effects on gastrointestinal and colonic motor functions in irritable bowel syndrome, with results posted after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Cannabinoid agonist

Snippet

Sponsor: Mayo Clinic | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2013-05-07